New heart-on-a-chip technology combats cardiac damage in Duchenne muscular dystrophy

A new "heart-on-a-chip" technology is being developed to combat cardiac damage in Duchenne muscular dystrophy. The BEAT Project, funded by Duchenne Parent Project Spain, will create a lab-grown human heart tissue model to monitor and test drug candidates for cardiomyopathy, a leading cause of death in DMD patients. This initiative aims to accelerate drug discovery for Duchenne and potentially other heart conditions, with families actively involved in guiding the research.